Practitionersl inl Primaryl Carel IIl Review|l
Wilkesl (Latestl 2026/l 2027l Update)l 100%l
Verifiedl Questionsl &l Answersl |l Gradel A
Q:l Whatl isl thel impactl ofl agingl servicesl onl NPl practice?
Answer:
Increasedl areasl ofl NPl workl inl underservedl areas,l particularlyl inl agingl services.
Q:l Whatl shouldl NPsl dol tol ensurel compliancel withl standardl care?
Answer:
Practicel withinl thel requirementsl ofl theirl nursel practicel actl andl organizationall policies.
Q:l Whatl shouldl bel addressedl tol ensurel patientl comfortl inl terminall care?
Answer:
Fatigue,l nausea,l orl vomiting.
Q:l Whatl toolsl canl bel usedl tol providel accuratel prognosisl inl palliativel care?
Answer:
Palliativel carel toolsl andl predictors.
Q:l Whatl signsl indicatel thatl al patientl isl nearingl death?
Answer:
,Skinl changes,l alteredl breathingl patterns,l andl changesl inl mentall status.
Q:l Howl shouldl al clinicianl determinel thel timel ofl death?
Answer:
Byl notingl thel absencel ofl breathingl andl cardiacl functionl forl 1l minute.
Q:l Whatl isl somaticl pain?
Answer:
Painl inl tissuel regions.
Q:l Whatl isl viscerall pain?
Answer:
Painl inl organs.
Q:l Whatl isl neuropathicl pain?
Answer:
Painl inl nervel roots.
Q:l Whatl isl consideredl acutel pain?
Answer:
Painl lastingl lessl thanl 1l month.
Q:l Whatl shouldl bel thel firstl stepl inl painl management?
Answer:
Maximizel nonopioidl choicesl beforel consideringl opioids.
,Q:l Whatl isl thel recommendedl approachl whenl prescribingl opioids?
Answer:
Orderl nol morel thanl thel expectedl durationl andl educatel thel patientl onl benefitsl andl risks.
Q:l Whatl shouldl bel establishedl whenl startingl opioidl therapy?
Answer:
Treatmentl goalsl forl painl andl function,l andl al planl forl discontinuation.
Q:l Whatl typel ofl medicationl shouldl bel prescribedl whenl startingl opioidl therapy?
Answer:
Immediate-releasel medicationl atl thel lowestl effectivel dose.
Q:l Whatl shouldl bel avoidedl whenl prescribingl opioids?
Answer:
Dosingl levelsl thatl yieldl diminishingl returnsl relativel tol risk.
Q:l Whatl arel thel first-linel medicationsl forl neuropathicl pain?
Answer:
Gabapentinl andl pregabalin.
Q:l Whatl isl thel recommendedl dosagel forl gabapentin?
Answer:
100-300l mgl oncel daily,l withl thel abilityl tol titratel up.
, Q:l Whatl shouldl bel avoidedl inl cardiacl patientsl whenl prescribingl SNRIs?
Answer:
Venlafaxinel duel tol potentiall EKGl changes.
Q:l Whichl tricyclicl antidepressantsl arel recommendedl forl neuropathicl pain?
Answer:
Nortriptylinel andl desipramine.
Q:l Whatl shouldl notl bel coprescribedl withl SNRIs?
Answer:
Tricyclicl Antidepressantsl (TCAs).
Q:l Whatl isl thel firstl recommendationl ofl thel CDCl painl managementl guidelinesl forl
opioids?
Answer:
Nonopioidl therapiesl arel atl leastl asl effectivel asl opioidsl forl manyl acutel pains.
Q:l Whatl shouldl cliniciansl dol whenl selectingl opioidsl forl patients?
Answer:
Selectl immediate-releasel opioidsl first,l asl theyl arel leastl likelyl tol leadl tol addiction.
Q:l Whatl isl thel recommendationl regardingl opioidl dosagel forl opioid-naïvel patients?
Answer:
Prescribel thel lowestl effectivel dosage.